Stanford University Medical Center
Stanford University Medical Center
Palo Alto, California, United States10 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Platform Clinical Study for Conquering Scleroderma | Skin and Connective Tissue Diseases, connective tissue disorder, diffuse scleroderma, interstitial lung disease, lung disorder, respiratory system disorder, scleroderma, skin disorder, systemic sclerosis | Recruiting | Phase 2 | 2026-08-18 | NCT06195072 | |
| KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 2 / Phase 3 | 2026-07-29 | NCT06193889 | |
| Personalized Blood Transfusion Protocol for Cardiac Patients | Hemic and Lymphatic Diseases, anemia, hematologic disorder | Not yet recruiting | Not applicable | 2026-06-30 | NCT07671469 | |
| Brain Oxygen Optimization in Severe TBI, Phase 3 | Brain Injuries, Traumatic, Craniocerebral Trauma, Hypoxia, Hypoxia, Brain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injury | Active, not recruiting | Not applicable | 2026-05-05 | NCT03754114 | |
| Rapid Non-Invasive Brain Stimulation for Hoarding Disorder | Hoarding Disorder, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, anxiety disorder, communication disorder, language disorder, nervous system disorder, obsessive-compulsive disorder, psychiatric disorder, speech disorder | Recruiting | Not applicable | 2026-04-22 | NCT06712914 | |
| Avapritinib With Decitabine in Patients With SM-AHN | Systemic Mastocytosis With an Associated Hematologic Neoplasm | Recruiting | Phase 1 | 2026-04-01 | NCT06327685 | |
| MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study) | anxiety disorder, obsessive-compulsive disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-03-05 | NCT05783817 | |
| Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Active, not recruiting | Not applicable | 2025-07-20 | NCT02000115 | |
| KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute myeloid leukemia, bone marrow disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myelodysplastic syndrome, myeloid leukemia, neoplasm | Enrolling by invitation | Phase 2 | 2025-05-04 | NCT02646839 | |
| KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 2 | 2025-01-13 | NCT06384976 |